The survival rates of mice carrying B16F10-IL-1β tumours (83.3%) were significantly better than for mice carrying tumours arising from B16F10-pro-IL-1β (25.0%, p = 0.003) or B16F10-vector (33.3%, p = 0.006) cells (Fig 5E). Here, IL1B is linked to neoplasm.